Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biosyent Inc (TSE:RX)
TSXV:RX
Holding TSE:RX?
Track your performance easily
RX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$8.24 - C$11.74
Previous CloseC$11.26
Volume1.73K
Average Volume (3M)7.37K
Market Cap
C$130.55M
Enterprise ValueC$114.57M
Total Cash (Recent Filing)C$17.06M
Total Debt (Recent Filing)C$1.08M
Price to Earnings (P/E)18.4
Beta0.07
Next Earnings
Mar 19, 2025EPS Estimate
C$0.15Last Dividend Ex-Date
Nov 29, 2024Dividend Yield1.55%
Share Statistics
EPS (TTM)0.61
Shares Outstanding11,586,914
10 Day Avg. Volume5,200
30 Day Avg. Volume7,366
Standard Deviation0.08
R-Squared0.25
Alpha0.00717
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)3.77
Price to Sales (P/S)4.00
Price to Cash Flow (P/CF)46.80
P/FCF Ratio49.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$11.75Price Target Upside3.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Biosyent News
PremiumCompany Announcements
BioSyent Announces Share Repurchase Plan
PremiumCompany Announcements
BioSyent’s Q3 Sales Surge Amid Strategic Moves
PremiumCompany Announcements
BioSyent to Announce Q3 2024 Financial ResultsPremiumPre-Earnings
Is RX a Buy, Before Earnings?
PremiumCompany Announcements
BioSyent Expands with Tibelia Asset Acquisition
PremiumCompany Announcements
BioSyent Maintains Dividend, Signals GrowthOptions Prices
Currently, No data available
---
Ownership Overview
37.10% Insiders
0.41% Mutual Funds
<0.01% Other Institutional Investors
62.49% Public Companies and
Individual Investors
RX FAQ
What was Biosyent Inc’s price range in the past 12 months?
Biosyent Inc lowest stock price was C$8.24 and its highest was C$11.74 in the past 12 months.
What is Biosyent Inc’s market cap?
Currently, no data Available
When is Biosyent Inc’s upcoming earnings report date?
Biosyent Inc’s upcoming earnings report date is Mar 19, 2025 which is in 87 days.
How were Biosyent Inc’s earnings last quarter?
Biosyent Inc released its earnings results on Nov 20, 2024. The company reported C$0.2 earnings per share for the quarter, beating the consensus estimate of C$0.14 by C$0.06.
Is Biosyent Inc overvalued?
According to Wall Street analysts Biosyent Inc’s price is currently Undervalued.
Does Biosyent Inc pay dividends?
Biosyent Inc pays a Quarterly dividend of C$0.045 which represents an annual dividend yield of 1.55%. See more information on Biosyent Inc dividends here
What is Biosyent Inc’s EPS estimate?
Biosyent Inc’s EPS estimate is C$0.15.
How many shares outstanding does Biosyent Inc have?
Biosyent Inc has 11,594,101 shares outstanding.
What happened to Biosyent Inc’s price movement after its last earnings report?
Biosyent Inc reported an EPS of C$0.2 in its last earnings report, beating expectations of C$0.14. Following the earnings report the stock price went up 3.588%.
Which hedge fund is a major shareholder of Biosyent Inc?
Currently, no hedge funds are holding shares in TSE:RX
---
Biosyent Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$11.75 (3.52% Upside)
C$11.75 (3.52% Upside)
Insider Transactions
Sold Shares
Worth C$8.2M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.93%
12-Months-Change
Fundamentals
Return on Equity
19.77%
Trailing 12-Months
Asset Growth
9.84%
Trailing 12-Months
Company Description
Biosyent Inc
Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.
---
RX Stock 12 Month Forecast
Average Price Target
C$11.75
▲(3.52% Upside)
Technical Analysis
Best Analysts Covering RX
1 Year
1 Year Success Rate
6/6 ratings generated profit
1 Year Average Return
+18.12%
reiterated a buy rating last month
Copying David Martin PhD's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.12% per trade.
---